Institutional investors purchased a net $2.5 million shares of GSK during the quarter ended December 2013 and now own 11.14% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
NCB CAPITAL CO. Bought 57.9 Thousand shares of GlaxoSmithKline PLC
STRATEGIC ADVISERS, INC. Bought 21.0 Thousand shares of GlaxoSmithKline PLC
STANLEY-LAMAN GROUP LTD. Bought 11.6 Thousand shares of GlaxoSmithKline PLC